Pandion Therapeutics Surges To Record High On Merck's $1.85 Billion Buyout

Pandion Therapeutics Surges To Record High On Merck's $1.85 Billion Buyout

Pandion Therapeutics stock blasted to a record high Thursday on Merck's plan to buy the IPO stock for $1.85 billion. Pandion just recently wrapped its initial public offering in July.